Passively Targeted Curcumin-Loaded PEGylated PLGA Nanocapsules for Colon Cancer Therapy In Vivo.

Small 2015 Sep 3;11(36):4704-22. Epub 2015 Jul 3.

Institute of Pharmaceutical Science, King's College London, Franklin-Wilkins Building, 150 Stamford Street, London, SE1 9NH, UK.

Clinical applications of curcumin for the treatment of cancer and other chronic diseases have been mainly hindered by its short biological half-life and poor water solubility. Nanotechnology-based drug delivery systems have the potential to enhance the efficacy of poorly soluble drugs for systemic delivery. This study proposes the use of poly(lactic-co-glycolic acid) (PLGA)-based polymeric oil-cored nanocapsules (NCs) for curcumin loading and delivery to colon cancer in mice after systemic injection. Formulations of different oil compositions are prepared and characterized for their curcumin loading, physico-chemical properties, and shelf-life stability. The results indicate that castor oil-cored PLGA-based NC achieves high drug loading efficiency (≈18% w(drug)/w(polymer)%) compared to previously reported NCs. Curcumin-loaded NCs internalize more efficiently in CT26 cells than the free drug, and exert therapeutic activity in vitro, leading to apoptosis and blocking the cell cycle. In addition, the formulated NC exhibits an extended blood circulation profile compared to the non-PEGylated NC, and accumulates in the subcutaneous CT26-tumors in mice, after systemic administration. The results are confirmed by optical and single photon emission computed tomography/computed tomography (SPECT/CT) imaging. In vivo growth delay studies are performed, and significantly smaller tumor volumes are achieved compared to empty NC injected animals. This study shows the great potential of the formulated NC for treating colon cancer.

Download full-text PDF

Source
http://dx.doi.org/10.1002/smll.201403799DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4660879PMC
September 2015
2 Reads

Publication Analysis

Top Keywords

colon cancer
12
curcumin loading
8
mice systemic
8
internalize efficiently
4
efficiently ct26
4
ncs internalize
4
ct26 cells
4
reported ncs
4
wdrug/wpolymer% compared
4
compared reported
4
ncs curcumin-loaded
4
curcumin-loaded ncs
4
free drug
4
vitro leading
4
leading apoptosis
4
apoptosis blocking
4
blocking cell
4
activity vitro
4
therapeutic activity
4
≈18% wdrug/wpolymer%
4

References

(Supplied by CrossRef)

Shehzad et al.
J. Nanosci. Nanotechnol. 2014

Shieh et al.
ACS Nano 2010

Wang et al.
Nanoscale 2010

Yurgel et al.
Braz. J. Med. Biol. Res. 2013

Moinard-Checot et al.
J. Nanosci. Nanotechnol. 2006

Lopez-Lazaro et al.
Mol. Nutr. Food Res. 2008

Lin et al.
Clin. Cancer Res. 2007

Dorai et al.
Prostate 2001

Aggarwal et al.
Mol. Pharmacol. 2006

Menon et al.
Cancer Lett. 1999

Anand et al.
Mol. Pharm. 2007

Similar Publications